Medical research

FILE - In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. When precious vats of COVID-19 vaccine are finally ready, the ability to jab the lifesaving solution into the arms of Americans will require hundreds of millions of injections. (AP Photo/Ted S. Warren, File)
July 10, 2020 - 2:25 pm
When precious vats of COVID-19 vaccine are finally ready, jabbing the lifesaving solution into the arms of Americans will require hundreds of millions of injections. As part of its strategy to administer the vaccine as quickly as possible, the Trump administration has agreed to invest more than...
Read More
A man walks past an informational mural with messages in English and Swahili warning people about the dangers of the new coronavirus and how to prevent transmission, painted by youth artists from the Uweza Foundation, in the Kibera slum, or informal settlement, of Nairobi, Kenya Wednesday, July 8, 2020. Africa now has more than a half-million confirmed coronavirus cases, according to the Africa Centers for Disease Control and Prevention, but the true number of cases among Africa's 1.3 billion people is unknown as its 54 countries face a serious shortage of testing materials for the virus. (AP Photo/Brian Inganga)
July 09, 2020 - 8:58 am
JOHANNESBURG (AP) — The coronavirus pandemic in Africa is reaching “full speed” and it’s good to prepare for the worst-case scenario, the Africa Centers for Disease Control and Prevention chief said Thursday, after a South African official said a single province is preparing 1.5 million graves...
Read More
FILE -In this Monday, Sept. 3, 2019 file photo, the logo is pictured of the pharmaceutical giant Servier Laboratoires in Suresnes, outside Paris. French pharmaceutical company Servier Laboratories is facing millions of euros in potential fines after a massive trial around a diabetes drug used as a diet pill. The popular drug, called Mediator, became one of France’s biggest modern health scandals. The trial is wrapping up Monday, July 6, 2020 after more than six months of exceptional proceedings targeting Servier and France’s medicines watchdog. (AP Photo/Michel Euler, File)
July 06, 2020 - 6:55 am
PARIS (AP) — Accused of favoring profits over patients’ lives, French pharmaceutical company Servier Laboratories is facing millions of euros in potential fines and damages after a huge trial involving 6,500 plaintiffs who say the company allowed a diabetes drug to be widely and irresponsibly...
Read More
A Venezuelan migrant girl, wearing a protective face mask with a graphic version of the Virgin of Guadalupe, waits for a bus to travel to the border, after breaking camp in Bogota, Colombia, Thursday, July 2, 2020. Facing no work due to the COVID-19-related economic shutdown, hundreds of Venezuelan migrants are returning to their country. (AP Photo/Fernando Vergara)
WBEN Newsroom
July 02, 2020 - 10:56 pm
SEOUL, South Korea -- South Korea has reported 63 newly confirmed cases of COVID-19 as health authorities scramble to mobilize public health tools to the southwestern city of Gwangju, where more than 50 people were found sickened over the past week. The figures announced by the Korea Centers for...
Read More
People protest against Coronavirus trials in Africa, outside the University of the Witwatersrand in Johannesburg, South Africa, Wednesday, July 1, 2020. A protest against Africa’s first COVID-19 vaccine trial is underway as experts note a worrying level of resistance and misinformation around testing on the continent. (AP Photo/Themba Hadebe)
July 01, 2020 - 12:47 pm
JOHANNESBURG (AP) — Protesters against Africa’s first COVID-19 vaccine trial burned their face masks Wednesday as experts note a worrying level of resistance and misinformation around testing on the continent. Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” the CEO of the GAVI...
Read More
FILE - This Jan. 23, 2020 file photo shows a patient receiving a flu vaccination in Mesquite, Texas. According to a study released on Wednesday, June 24, 2020, flu vaccines for years were close to 60% effective against the flu strain that caused the most lab-confirmed illnesses last winter, but it proved only 31% effective last season. (AP Photo/LM Otero, File)
June 24, 2020 - 5:03 pm
NEW YORK (AP) — The flu vaccine did a disappointing job last winter in the U.S., and officials worry that might be a bad sign for the fall. Flu vaccines had been about 60% effective against the type of flu that caused the most lab-confirmed illnesses last winter, but last season's vaccine was only...
Read More
A vaccine volunteer gets an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg Wednesday, June 24, 2020. Africa’s first participation in a COVID-19 vaccine trial has begun as volunteers received injections developed at the University of Oxford in Britain. The large-scale trial is being conducted in South Africa, Britain and Brazil. (AP Photo/Siphiwe Sibeko)
June 24, 2020 - 9:49 am
JOHANNESBURG (AP) — Africa's first participation in a COVID-19 vaccine trial started Wednesday as volunteers received injections developed at the University of Oxford in Britain, while officials said the continent of 1.3 billion people cannot be left behind. The large-scale trial is being conducted...
Read More
Members of the Red Cross disinfects a facility at the CEASA, Rio de Janeiro's main wholesale market, amid the new coronavirus pandemic in Rio de Janeiro, Brazil, Tuesday, June 23, 2020. (AP Photo/Silvia Izquierdo)
June 23, 2020 - 6:53 pm
SAO PAULO (AP) — Brazil is testing an experimental coronavirus vaccine, but interim Health Minister Eduardo Pazuello acknowledged Tuesday that the government has yet to strike a deal to get it if it works. Other nations have already secured hundreds of millions of doses of the shot created by...
Read More
FILE - In this June 12, 2020, file photo, a health worker draws blood for COVID-19 antibody testing in Dearborn, Mich. A genetic analysis of COVID-19 patients published Wednesday, June 17, 2020, in the New England Journal of Medicine suggests a person's blood type may have some influence on whether they develop severe disease. (AP Photo/Paul Sancya, File)
June 17, 2020 - 8:01 pm
A genetic analysis of COVID-19 patients suggests that blood type might influence whether someone develops severe disease. Scientists who compared the genes of thousands of patients in Europe found that those who had Type A blood were more likely to have severe disease while those with Type O were...
Read More
June 17, 2020 - 12:04 pm
MOSCOW (AP) — Clinical trials of a Russian coronavirus vaccine have started Wednesday, the Health Ministry said in a statement. Two forms of the vaccine developed by the Moscow-based Gamaleya research institute — liquid and powder for injections — will be tested on two groups of volunteers, 38...
Read More

Pages